Research output per year
Research output per year
Personal profile
Fingerprint
Dive into the research topics where Christian Reinhard Mayr is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
The importance of preclinical models for cholangiocarcinoma drug discovery
Krendl, F. J., Primavesi, F. (Co-author), Oberhuber, R., Neureiter, D. (Co-author), Ocker, M., Bekric, D. (Co-author), Kiesslich, T. (Co-author) & Mayr, C. (Last author), 7 Feb 2025, In: EXPERT OPINION ON DRUG DISCOVERY. 12 p.Research output: Contribution to journal › Review article › peer-review
-
Multi-array miRNA approach and associated protein expression profiling for the development of predictive and prognostic biomarkers in esophageal adenocarcinoma
Neureiter, D., Mayr, C. R., Neureiter, E., Winkelmann, P., Neumayer, B., Klieser, E., Wagner, A., Hufnagl, C., Emmanuel, K., Holzinger, J., Koch, O. O., Kiesslich, T. & Varga, M., Feb 2024, In: Oncology Research and Treatment. 2024, 47, p. 70 1 p., 493.Research output: Contribution to journal › Abstract (Journal) › peer-review
-
New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al
Kiesslich, T. (First author), Mayr, C. (Co-author), Bekric, D. (Co-author) & Neureiter, D. (Last author), Jun 2024, In: TRANSLATIONAL ONCOLOGY. 44, p. 101820Research output: Contribution to journal › Letter to the editor › peer-review
Open Access -
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer
Ablinger, C., Neureiter, D. (Co-author), Mähr, T., Mayr, C. (Co-author), Kiesslich, T. (Co-author), Maeding, N. (Co-author), Valenta, I., Ardelt, M. (Co-author), Wilhelm, F., Neureiter, E., Ritter, M. (Co-author), Pachmayr, J. (Co-author) & Huber-Cantonati, P. (Last author), 31 Dec 2024, In: CANCER BIOLOGY & THERAPY. 25, 1, p. 2439057 14 p., 2439057.Research output: Contribution to journal › Original Article › peer-review
Open Access -
The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells
Bekric, D. (First author), Kiesslich, T. (Co-author), Ocker, M., Winklmayr, M. (Co-author), Ritter, M. (Co-author), Dobias, H. (Co-author), Beyreis, M. (Co-author), Neureiter, D. (Co-author) & Mayr, C. (Last author), 11 Apr 2024, In: PLOS ONE. 19, 4, p. e0302050 22 p., e0302050.Research output: Contribution to journal › Original Article › peer-review
Open Access1 Citation (Web of Science)
Projects
- 9 Finished
-
EZH1, a new therapeutic target for biliary tract cancer?
Mayr, C. R. (PI)
1/04/22 → 1/04/23
Project: Research
-
Ferroptosis, a new approach to target biliary tract cancer?
Mayr, C. R. (PI)
1/02/21 → 1/02/22
Project: Research
-
Evaluation of Tazemetostat as a therapeutically relevant substance in biliary tract cancer
Mayr, C. R. (PI)
1/03/19 → 1/03/20
Project: Research
-
Role of volume-regulated chloride channels in biliary tract cancer cisplatin resistance
Jakab, M. (PI), Helm, K. (Further contributor), Mayr, C. R. (CoPI), Kiesslich, T. (Further contributor), Beyreis, M. (Further contributor), Kittl, M. (Further contributor) & Ritter, M. (Further contributor)
1/04/18 → 1/04/20
Project: Research
-
Establishing the cardiotonic steroid ouabain as a potent anti-cancer drug against biliary tract cancer – Step one
Dobias, H. (PI), Mayr, C. R. (Further contributor), Kiesslich, T. (Further contributor), Beyreis, M. (Further contributor) & Jakab, M. (Further contributor)
3/01/18 → 3/01/19
Project: Research
Prizes
-
Herz-Kreislauf-Atmung I - Respiratorisches System - Humanmedizin Bachelor Master
Mayr, C. R. (Cooperation)
2025 → …Activity: Other scientific activities › Teaching Activity
-
LBIAR Partnerboard Vertretung PMU (Stellvertreter)
Mayr, C. R. (Cooperation)
2024 → …Activity: Other scientific activities › Committee
-
Herz-Kreislauf-Atmung II - Kardiologie / Pathophysiologie kardiovaskuläres System - Humanmedizin Bachelor Master
Mayr, C. R. (Cooperation)
2024 → …Activity: Other scientific activities › Teaching Activity
-
Niedrig-dosiertes Aspirin in der Primärprävention von Herz-Kreislauf-Erkrankungen
Mayr, C. R. (Supervisor)
2024 → …Activity: Examination, Supervision or Reviewing of graduation work › Supervision
-
UV-Strahlungsinduziertes Photoaging und mögliche Protektion durch Sonnencreme
Mayr, C. R. (Supervisor)
2024 → …Activity: Examination, Supervision or Reviewing of graduation work › Supervision